Second-generation antipsychotics - a panacea?
Date
2004
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
AOSIS
Abstract
The introduction of the second-generation antipsychotics (SGAs) (atypical antipsychotics) for the treatment of psychotic disorders has changed the goals of modern therapeutic outcomes. No longer are positive symptoms of psychosis in schizophrenia the only outcomes measured, but dimensions including negative and cognitive symptoms are now crucial to determining efficacy. As a result outcomes in these areas are increasingly impacting on our choice of treatment.
Description
CITATION: Carey, P. D., Stein, D. & Emsley, R. 2004. Second-generation antipsychotics - a panacea? South African Journal of Psychiatry, 10(4):a121, doi:10.4102/sajpsychiatry.v10i4.121.
The original publication is available at https://sajp.org.za
The original publication is available at https://sajp.org.za
Keywords
Citation
Carey, P. D., Stein, D. & Emsley, R. 2004. Second-generation antipsychotics - a panacea? South African Journal of Psychiatry, 10(4):a121, doi:10.4102/sajpsychiatry.v10i4.121.